The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 · Nature · 3,425 citations
https://doi.org/10.1038/s41586-019-1705-2
D
Daniel K. Nomura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
288
Papers
25.7K
Citations
80
h-index
171
i10-index
Daniel K. Nomura is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Protein Degradation and Inhibitors & Ubiquitin and proteasome pathways & Click Chemistry and Applications. The author has an h-index of 80, co-authored 245 publications.
ORCID: 0000-0003-1614-8360Papers by this author
worksExogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State
2019 · Cell chemical biology · 1,069 citations
https://doi.org/10.1016/j.chembiol.2018.11.016
Advances in covalent drug discovery
2022 · Nature Reviews Drug Discovery · 707 citations
https://doi.org/10.1038/s41573-022-00542-z
Microglia Dictate the Impact of Saturated Fat Consumption on Hypothalamic Inflammation and Neuronal Function
2014 · Cell Reports · 602 citations
https://doi.org/10.1016/j.celrep.2014.11.018
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
2016 · Nature Medicine · 523 citations
https://doi.org/10.1038/nm.4055
Reimagining Druggability Using Chemoproteomic Platforms
2021 · Accounts of Chemical Research · 179 citations
https://doi.org/10.1021/acs.accounts.1c00065
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat